Literature DB >> 21382523

Sequence homology and structural analysis of plasmepsin 4 isolated from Indian Plasmodium vivax isolates.

Manmeet Rawat1, Sonam Vijay, Yash Gupta, Rajnikant Dixit, P K Tiwari, Arun Sharma.   

Abstract

Plasmodium vivax malaria is a globally widespread disease responsible for 50% of human malaria cases in Central and South America, South East Asia and Indian subcontinent. The rising severity of the disease and emerging resistance of the parasite has emphasized the need for the search of novel therapeutic targets to combat P. vivax malaria. Plasmepsin 4 (PM4) a food vacuole aspartic protease is essential in parasite functions and viability such as initiating hemoglobin digestion and processing of proteins and is being looked upon as potential drug target. Although the plasmepsins of Plasmodium falciparum have been extensively studied, the plasmepsins of P. vivax are not well characterized. This is the first report detailing complete PM4 gene analysis from Indian P. vivax isolates. Blast results of sequences of P. vivax plasmepsin 4 (PvPM4) shows 100% homology among isolates of P. vivax collected from different geographical regions of India. All of the seven Indian isolates did not contain intron within the coding region. Interestingly, PvPM4 sequence analysis showed a very high degree of homology with all other sequences of Plasmodium species available in the genebank. Our results strongly suggest that PvPM4 are highly conserved except a small number of amino acid substitutions that did not modify key motifs at active site formation for the function or the structure of the enzymes. Furthermore, our study shows that PvPM4 occupies unique phylogenetic status within Plasmodium group and sufficiently differ from the most closely related human aspartic protease, cathepsin D. The analysis of 3D model of PM4 showed a typical aspartic protease structure with bi-lobed, compact and distinct peptide binding cleft in both P. vivax and P. falciparum. In order to validate appropriate use of PM4 as potential anti-malarial drug target, studies on genetic and structural variations among P. vivax plasmepsins (PvPMs) from different geographical regions are of utmost importance for drugs and vaccine designs for anti-malarial strategies.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21382523     DOI: 10.1016/j.meegid.2011.02.024

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  6 in total

Review 1.  Malaria evolution in South Asia: knowledge for control and elimination.

Authors:  Krishnamoorthy Narayanasamy; Laura Chery; Analabha Basu; Manoj T Duraisingh; Ananias Escalante; Joseph Fowble; Jennifer L Guler; Thurston Herricks; Ashwani Kumar; Partha Majumder; Jennifer Maki; Anjali Mascarenhas; Janneth Rodrigues; Bikram Roy; Somdutta Sen; Jayanthi Shastri; Joseph Smith; Neena Valecha; John White; Pradipsinh K Rathod
Journal:  Acta Trop       Date:  2012-01-14       Impact factor: 3.112

2.  Protease-associated cellular networks in malaria parasite Plasmodium falciparum.

Authors:  Timothy G Lilburn; Hong Cai; Zhan Zhou; Yufeng Wang
Journal:  BMC Genomics       Date:  2011-12-23       Impact factor: 3.969

3.  K562 erythroleukemia line as a possible reticulocyte source to culture Plasmodium vivax and its surrogates.

Authors:  Romy Kronstein-Wiedemann; Onny Klop; Jessica Thiel; Peter Milanov; Claudia Ruhland; Lars Vermaat; Clemens H M Kocken; Torsten Tonn; Erica M Pasini
Journal:  Exp Hematol       Date:  2020-01-30       Impact factor: 3.084

4.  Imperfect duplicate insertions type of mutations in plasmepsin V modulates binding properties of PEXEL motifs of export proteins in Indian Plasmodium vivax.

Authors:  Manmeet Rawat; Sonam Vijay; Yash Gupta; Pramod Kumar Tiwari; Arun Sharma
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

5.  Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against Plasmodium vivax Vivapain-3 (VP-3).

Authors:  Madhu Sudhana Saddala; Pradeepkiran Jangampalli Adi
Journal:  Heliyon       Date:  2018-05-08

6.  Plasmodium vivax metacaspase 1 (PvMCA1) catalytic domain is conserved in field isolates from Brazilian Amazon.

Authors:  Hugo Amorim Dos Santos de Souza; Victor Fernandes Escafa; Carolina Moreira Blanco; Bárbara de Oliveira Baptista; Jenifer Peixoto de Barros; Evelyn Ketty Pratt Riccio; Aline Beatriz Mello Rodrigues; Gisely Cardoso de Melo; Marcus Vinícius Guimarães de Lacerda; Rodrigo Medeiros de Souza; Josué da Costa Lima-Junior; Ana Carolina Ramos Guimarães; Fabio Faria da Mota; João Hermínio Martins da Silva; Cláudio Tadeu Daniel-Ribeiro; Lilian Rose Pratt-Riccio; Paulo Renato Rivas Totino
Journal:  Mem Inst Oswaldo Cruz       Date:  2021-05-31       Impact factor: 2.743

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.